CFTR and cystic fibrosis: The first molecule prevented the degradation of a mutated form of CFTR (ΔF508-CFTR), a common cystic fibrosis (CF) mutation, which is unstable and therefore, leads to rapid polyubiquitination and degradation of the protein, causing the phenotype observed in this disease.